nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anthracyclines in non-small-cell lung cancer: Do they have a therapeutic role?
|
Martoni, A. |
|
|
10 |
S5 |
p. S19-S23 |
artikel |
2 |
Chemoradiotherapy interactions and lung toxicity
|
Trott, K.-R. |
|
|
10 |
S5 |
p. S77-S81 |
artikel |
3 |
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia
|
Del Mastro, L. |
|
|
10 |
S5 |
p. S91-S94 |
artikel |
4 |
Cisplatin and gemcitabine in non-small-cell lung cancer
|
Cartei, G. |
|
|
10 |
S5 |
p. S57-S62 |
artikel |
5 |
Copyright
|
|
|
|
10 |
S5 |
p. ii |
artikel |
6 |
Docetaxel (Taxotere®) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer*
|
Ornstein, D.L. |
|
|
10 |
S5 |
p. S35-S40 |
artikel |
7 |
Docetaxel (Taxotere®) in the neo-adjuvant setting in non-small-cell lung cancer
|
Mattson, K. |
|
|
10 |
S5 |
p. S69-S72 |
artikel |
8 |
Editorial
|
Cartei, G. |
|
|
10 |
S5 |
p. S1 |
artikel |
9 |
Ifosfamide in non-small-cell lung cancer
|
Rosell, R. |
|
|
10 |
S5 |
p. S25-S28 |
artikel |
10 |
Molecular epidemiology of lung cancer*
|
Shields, P.G. |
|
|
10 |
S5 |
p. S7-S11 |
artikel |
11 |
Multidrug resistance in non-small-cell lung cancer
|
Scagliotti, G.V. |
|
|
10 |
S5 |
p. S83-S86 |
artikel |
12 |
Paclitaxel-based therapy in non-small-cell lung cancer: Improved third generation chemotherapy
|
Greco, F.A. |
|
|
10 |
S5 |
p. S63-S67 |
artikel |
13 |
Retinoids in lung cancer chemoprevention and treatment
|
Toma, S. |
|
|
10 |
S5 |
p. S95-S102 |
artikel |
14 |
Table of Contents
|
|
|
|
10 |
S5 |
p. i |
artikel |
15 |
The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC)
|
Ardizzoni, A. |
|
|
10 |
S5 |
p. S13-S17 |
artikel |
16 |
The epidemiology of lung cancer
|
Franceschi, S. |
|
|
10 |
S5 |
p. S3-S6 |
artikel |
17 |
Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection
|
Spina, M. |
|
|
10 |
S5 |
p. S87-S90 |
artikel |
18 |
The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer
|
Kelly, K. |
|
|
10 |
S5 |
p. S53-S56 |
artikel |
19 |
The role of surgery in integrated therapies for non-small-cell lung cancer
|
Sartori, F. |
|
|
10 |
S5 |
p. S73-S76 |
artikel |
20 |
Tirapazamine: A new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer
|
Wouters, B.G. |
|
|
10 |
S5 |
p. S29-S33 |
artikel |
21 |
Vinorelbine (Navelbine®) in the treatment of non-small-cell lung cancer: Recent developments in combination chemotherapy and radiotherapy
|
Gralla, R. |
|
|
10 |
S5 |
p. S47-S51 |
artikel |
22 |
Vinorelbine (Navelbine®) in the treatment of non-small-cell lung cancer: Studies with single-agent therapy and in combination with cisplatin
|
Gralla, R. |
|
|
10 |
S5 |
p. S41-S45 |
artikel |